MML Investors Services
PTCT icon

MML Investors Services’s PTC Therapeutics PTCT Stock Holding History

MML Investors Services’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Buy
7,811
+180
+2% +$13K ﹤0.01% 2299
2026
Q1 		$520K Buy
7,631
+480
+7% +$34K ﹤0.01% 2196
2025
Q4 		$543K Sell
7,151
-3,438
-32% -$250K ﹤0.01% 2208
2025
Q3 		$650K Buy
10,589
+2,339
+28% +$122K ﹤0.01% 2008
2025
Q2 		$403K Buy
+8,250
New +$392K ﹤0.01% 2230
2024
Q1 		– Sell
-15,295
Closed -$422K – 2553
2023
Q4 		$422K Sell
15,295
-23,907
-61% -$547K ﹤0.01% 1848
2023
Q3 		$879K Buy
39,202
+10,302
+36% +$383K ﹤0.01% 1292
2023
Q2 		$1.18M Buy
28,900
+5,175
+22% +$253K 0.01% 1155
2023
Q1 		$1.15M Sell
23,725
-2,175
-8% -$99.4K 0.01% 1002
2022
Q4 		$989K Sell
25,900
-1,950
-7% -$81.1K 0.01% 1156
2022
Q3 		$1.4M Sell
27,850
-25,900
-48% -$1.27M 0.01% 900
2022
Q2 		$2.15M Buy
53,750
+3,150
+6% +$110K 0.02% 722
2022
Q1 		$1.89M Buy
50,600
+3,425
+7% +$132K 0.01% 826
2021
Q4 		$1.88M Buy
47,175
+2,848
+6% +$109K 0.01% 794
2021
Q3 		$1.65M Buy
44,327
+6,400
+17% +$263K 0.01% 805
2021
Q2 		$1.6M Buy
37,927
+25,900
+215% +$1.11M 0.01% 799
2021
Q1 		$569K Buy
+12,027
New +$714K 0.01% 1198
2020
Q4 		– Sell
-6,127
Closed -$286K – 1697
2020
Q3 		$286K Buy
+6,127
New +$302K ﹤0.01% 1313

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MML Investors Services's PTCT Position: Q2 2026 in Review

MML Investors Services increased its PTC Therapeutics (PTCT) stake by 2.4% in Q2 2026, buying an estimated $13K and bringing the position to 7,811 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

MML Investors Services first reported a position in PTCT in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.15M in Q2 2022. 162 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • MML Investors Services held 7,811 shares of PTC Therapeutics worth $637K as of Q2 2026.
  • MML Investors Services bought 180 PTC Therapeutics shares in Q2 2026, an estimated $13K.
  • PTC Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2299 holding.
  • MML Investors Services first reported a position in PTC Therapeutics in Q3 2020 and has held it in 18 quarters since.
  • MML Investors Services's PTC Therapeutics position peaked at $2.15M in Q2 2022.
  • 162 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.